The first annual meeting of The Antibody Society’s Board of Directors was held on December 2, 2007. Following their retirement on July 6, 2022, we are recognizing the outstanding contributions of four founding members: Dr. Andrew Bradbury, Prof. Dennis Burton, Prof. Andreas Plückthun and Prof. Jamie Scott. In addition, we are acknowledging the strong contributions of Dr. Greg Adams who became a Director in 2013 and also retired on July 6th. Dr. Bradbury served as our first, and Prof. Scott as our second President. As stated by Dr. Bradbury: “the Society aimed to provide a forum and voice for the thousands of people working in this area and to help attract and encourage young students to all facets of the field”. Amongst other things, this initially was done by ensuring the excellent scientific content of the Antibody Engineering & Therapeutics conference. Since that time, the Society has grown into a mature and world-renowned non-profit trade organization with ~ 2400 members from academia, government agencies and industry, and financially supported by over 40 companies ranging from the smallest biotech companies to the largest pharma firms.
The Society thanks Drs Bradbury and Adams and Profs Burton, Plückthun and Scott for their dedication and service, which has enabled the Society to grow and thrive. Each retiring member was given a special award for outstanding contributions to the Society, in the form of a piece of art which was specifically commissioned for them.
More information about The Antibody Society’s Board of Directors can be found here.